The Coagulation and Hematology Laboratories at New York Presbyterian/Weill Cornell perform and have extensive experience in a wide range of both routine and specialized coagulation/hematology testing for general screening and for diagnostic evaluation of patients with coagulopathies and blood abnormalities. Sabrina Racine-Brzostek, MD, PhD, is the medical director of the laboratory.
The laboratories are College of American Pathologists (CAP) accredited and operate under a permit issued by the New York State Department of Health, which reflect the laboratory’s high standards in compliance and quality assurance standards in assay development, validation and implementation.
The Coagulation and Hematology Laboratories serve NewYork-Presbyterian/Weill Cornell Medical Center campus, including the David H. Koch Center and Alexandra Cohen Hospital for Women and Newborns. It also performs testing for its extensive outpatient outreach programs.
Weill Cornell is a Hemophilia Treatment Center, a Thalassemia Treatment Center and has a vibrant Sickle Cell Treatment Program. The Coagulation and Hematology lab supports these programs by offering sophisticated and accurate diagnostic testing.
A large variety of tests are performed in the lab (which are described in the NYP/WC Clinical Laboratories test menu). They include routine testing, such as aPTT, PT, fibrinogen, D-dimer, CBC with and differentials and urinalysis. The labs also perform more specialized testing, including assays evaluating coagulation factors and factor inhibitors, von Willebrand disease testing, thrombophilia evaluations, Heparin-Induced Thrombocytopenia testing, platelet aggregation studies and hemoglobinopathy evaluations.